Michigan House Bill HB5420

Michigan 2025-2026 Regular Session

• Introduced: 12/18/25
• Refer: 12/18/25

Caption

Health facilities: hospitals; certain drug screens conducted in hospitals; require to include a test for substances determined by rule and to provide certain reporting. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 21525.

Impact

The implications of HB5420 are substantial for public health policy in Michigan. By requiring drug tests to include specified substances, the legislation seeks to improve data collection and trend analysis concerning drug use and overdose incidents. This information will be vital for identifying risk factors and informing state healthcare strategies. DHHS is tasked with creating rules for the list of qualified substances and reviewing it annually, thereby allowing for adaptive responses to changing public health needs in drug monitoring.

Summary

House Bill 5420 amends the Public Health Code of Michigan by adding section 21525, which mandates that hospitals conducting drug screens for potential overdose cases include tests for certain qualified substances. This legislative change is aimed at ensuring that hospitals provide comprehensive drug screening, which could significantly enhance the state's ability to monitor and address drug overdose cases effectively. The bill outlines the responsibilities of hospitals to report these test results to the Department of Health and Human Services (DHHS) in a prescribed format while ensuring patient confidentiality by prohibiting the inclusion of any identifying information.

Contention

While the bill aims to enhance public health through improved monitoring, questions may arise regarding the extent of government oversight and the implications for patient privacy. The mandatory reporting stipulations could lead to concerns about how data is managed and used by health authorities. Some stakeholders might argue that while the intent is to reduce risk and improve treatment outcomes, the potential for misuse of data or misinterpretation of screening results could present challenges. Additionally, the requirement for hospitals may also evoke debates about resource allocation and logistical feasibility in implementing these statutory changes.